Is pre-diabetes a pre-diagnosis that crosses the fine line between pursuing good health and medicalizing all of life? In their new analysis published this week by BMJ, John Yudkin and Victor Montori suggest that it is. Go to: http://www.bmj.com/content/349/bmj.g4485

A study in PLOS Medicine revealed obese participants with the lowest genetic risk for diabetes had higher odds of disease onset than their normal-weight counterparts with the highest genetic risk. Researchers said the findings suggest that obesity elevates the risk of diabetes regardless of genetic profile, and that disease prevention programs that focus on weight loss may trump genetics-based…

As of the end of March 2014, a total of 7,400 subjects have been pre-screened, 2,450 have been screened, and 1,050 subjects found eligible for the clinical trial. The average age of the eligible subjects so far is 52 y, divided into 735 females and 315 males. During the initial LCD phase (using Cambridge Weight Plan LCD products), a total of 80% of the subjects have achieved the target weight loss as hypothesized in the PREVIEW concept.

Professors Jennie Brand-Miller and Stephen Colagiuri have been officially notified that they have received AUD334,000 in the latest round of grants from the National Health and Medical Research Council. This funding will contribute to the costs of PREVIEW in 2014 and 2015.

Some good news! Professor Angelo Tremblay has been verbally informed that he will receive a 3-year grant totalling about $588,000 Canadian Dollars. Written confirmation to follow. Congratulations Angelo.